Adjunctive minocycline for schizophrenia: A meta-analysis of randomized controlled trials

@article{Xiang2017AdjunctiveMF,
  title={Adjunctive minocycline for schizophrenia: A meta-analysis of randomized controlled trials},
  author={Y. Xiang and W. Zheng and Shi-bin Wang and X. Yang and Yu-Tao Xiang},
  journal={European Neuropsychopharmacology},
  year={2017},
  volume={27},
  pages={8-18}
}
  • Y. Xiang, W. Zheng, +2 authors Yu-Tao Xiang
  • Published 2017
  • Medicine
  • European Neuropsychopharmacology
  • This study aimed to conduct a meta-analysis of the efficacy and safety of adjunctive minocycline for schizophrenia. Randomized controlled trials (RCTs) comparing adjunctive minocycline with placebo in patients with schizophrenia were included in the meta-analysis. Two independent investigators extracted and synthesized data. Standard mean differences (SMDs), risk ratio (RR) ±95% confidence intervals (CIs) and the number-needed-to-harm (NNH) were calculated. Eight RCTs with 548 schizophrenia… CONTINUE READING
    Adjunctive minocycline for major mental disorders: A systematic review
    6

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 46 REFERENCES
    Minocycline supplementation for treatment of negative symptoms in early-phase schizophrenia: A double blind, randomized, controlled trial
    92
    Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms
    46
    A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia.
    298
    Clozapine versus typical neuroleptic medication for schizophrenia.
    190